J Korean Med Sci.  2017 Nov;32(11):1840-1847. 10.3346/jkms.2017.32.11.1840.

Prevalence and Clinical Characteristics of Metabolically Healthy Obesity in Korean Children and Adolescents: Data from the Korea National Health and Nutrition Examination Survey

• Yoon DY
• Lee YA
• Lee J
• Kim JH
• Shin CH
• Yang SW

• KMID: 2390312
• DOI: http://doi.org/10.3346/jkms.2017.32.11.1840

Abstract

Metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) are differentiated by the presence of cardiometabolic risk factors (CMRFs) and insulin resistance (IR). This study aimed to evaluate the prevalence and clinical characteristics of MHO in Korean children and adolescents and to investigate the anthropometric, laboratory, and lifestyle predictors of MHO. This study included data from 530 obese subjects, aged 10-19 years, obtained from the Fourth Korea National Health and Nutrition Examination Survey. Subjects were classified into MHO and MUO groups according to the presence of CMRF (MHO(CMRF)/MUO(CMRF)) and degree of IR (MHO(IR)/MUO(IR)). Demographic, anthropometric, cardiometabolic, and lifestyle factors were compared between the groups. Logistic regression analysis and receiver operating characteristic curve analysis were performed to identify factors that predicted MHO. The prevalence of MHO(CMRF) and MHO(IR) in obese Korean youth was 36.8% (n = 197) and 68.8% (n = 356), respectively. CMRF profiles were significantly less favorable in MUO children. Longer and more vigorous physical activity and less protein intake were associated with MHO(CMRF) phenotype. The best predictors of MHO(CMRF) and MHO(IR) were waist circumference (odds ratio [OR], 0.82; 95% confidence interval [CI], 0.77-0.88; P < 0.001) and body mass index (BMI) standard deviation score (OR, 0.24; 95% CI, 0.15-0.39; P < 0.001), respectively. The prevalence of MHO differed depending on how it was defined. To adequately manage obesity in youth, the approach to individuals with MHO and MUO should be personalized due to variation in clinical characteristics. Longitudinal studies are needed to evaluate long-term consequences of MHO.

Keyword

Metabolically Healthy Obesity; Prevalence; Children; Korea

MeSH Terms

Adolescent*
Body Mass Index
Child*
Humans
Insulin Resistance
Korea*
Life Style
Logistic Models
Longitudinal Studies
Motor Activity
Nutrition Surveys*
Obesity
Obesity, Metabolically Benign*
Phenotype
Prevalence*
Risk Factors
ROC Curve
Waist Circumference

Figure

• 

  Fig. 1 Distribution of the number of CMRFs by MHO and MUO phenotype defined according to different criteria. MHO = metabolically healthy obesity, MUO = metabolically unhealthy obesity, CMRF = cardiometabolic risk factor, IR = insulin resistance.

• 

  Fig. 2 Proportion of CMRFs in children and adolescents with MUO. MHO = metabolically healthy obesity, MUO = metabolically unhealthy obesity, CMRF = cardiometabolic risk factor, IR = insulin resistance, HDL = high density lipoprotein.

• 

  Fig. 3 ROC curve for BMI SDS, WHR, and WC to detect MUO by definition. (A) MUOCMRF with an AUC (95% CI) of 0.699 (0.698–0.700) for BMI SDS, 0.744 (0.743–0.745) for WHR, and 0.761 (0.760–0.761) for WC (P < 0.001), (B) MUOIR with an AUC (95% CI) of 0.676 (0.675–0.677) for BMI SDS, 0.635 (0.634–0.636) for WHR, and 0.593 (0.592–0.594) for WC (P < 0.001). ROC = receiver operating characteristic, BMI = body mass index, SDS = standard deviation score, WHR = waist-height ratio, WC = waist circumference, MUO = metabolically unhealthy obesity, CMRF = cardiometabolic risk factor, AUC = area under the curve, CI = confidence interval, IR = insulin resistance.

Reference

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384:766–781.

2. Oh K, Jang MJ, Lee NY, Moon JS, Lee CG, Yoo MH, Kim YT. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatr. 2008; 51:950–955.

3. Reilly JJ. Descriptive epidemiology and health consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab. 2005; 19:327–341.

4. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet. 2002; 360:473–482.

5. Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism. 2001; 50:1499–1504.

6. Vukovic R, Milenkovic T, Mitrovic K, Todorovic S, Plavsic L, Vukovic A, Zdravkovic D. Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents. Eur J Pediatr. 2015; 174:1649–1655.

7. Prince RL, Kuk JL, Ambler KA, Dhaliwal J, Ball GD. Predictors of metabolically healthy obesity in children. Diabetes Care. 2014; 37:1462–1468.

8. Weghuber D, Zelzer S, Stelzer I, Paulmichl K, Kammerhofer D, Schnedl W, Molnar D, Mangge H. High risk vs. “metabolically healthy” phenotype in juvenile obesity - neck subcutaneous adipose tissue and serum uric acid are clinically relevant. Exp Clin Endocrinol Diabetes. 2013; 121:384–390.

9. Camhi SM, Waring ME, Sisson SB, Hayman LL, Must A. Physical activity and screen time in metabolically healthy obese phenotypes in adolescents and adults. J Obes. 2013; 2013:984613.

10. Plourde G, Karelis AD. Current issues in the identification and treatment of metabolically healthy but obese individuals. Nutr Metab Cardiovasc Dis. 2014; 24:455–459.

11. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V, Sladek R, Rabasa-Lhoret R. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes. 2011; 35:971–981.

12. Blüher S, Schwarz P. Metabolically healthy obesity from childhood to adulthood - does weight status alone matter? Metabolism. 2014; 63:1084–1092.

13. Mangge H, Zelzer S, Puerstner P, Schnedl WJ, Reeves G, Postolache TT, Weghuber D. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity (Silver Spring). 2013; 21:E71–E77.

14. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr. 2010; 64:1043–1051.

15. Yoo HK, Choi EY, Park EW, Cheong YS, Bae RA. Comparison of metabolic characteristics of metabolically healthy but obese (MHO) middle-aged men according to different criteria. Korean J Fam Med. 2013; 34:19–26.

16. Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, Perry IJ. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One. 2013; 8:e76188.

17. Lee K. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr. 2009; 18:280–284.

18. Brochu M, Tchernof A, Dionne IJ, Sites CK, Eltabbakh GH, Sims EA, Poehlman ET. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab. 2001; 86:1020–1025.

19. Jennings CL, Lambert EV, Collins M, Joffe Y, Levitt NS, Goedecke JH. Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women. Obesity (Silver Spring). 2008; 16:1602–1609.

20. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, Chun C, Khang YH, Oh K. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014; 43:69–77.

21. Moon JS, Lee SY, Nam CM, Choi JM, Choe BK, Seo JW, Oh K, Jang MJ, Hwang SS, Yoo MH, et al. 2007 Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr. 2008; 51:1–25.

22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28:412–419.

23. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes. 2007; 8:299–306.

24. Yi KH, Hwang JS, Kim EY, Lee SH, Kim DH, Lim JS. Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: a population-based study. Diabetes Res Clin Pract. 2014; 103:106–113.

25. Sénéchal M, Wicklow B, Wittmeier K, Hay J, MacIntosh AC, Eskicioglu P, Venugopal N, McGavock JM. Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese youth. Pediatrics. 2013; 132:e85–e92.

26. Reinehr T, Wolters B, Knop C, Lass N, Holl RW. Strong effect of pubertal status on metabolic health in obese children: a longitudinal study. J Clin Endocrinol Metab. 2015; 100:301–308.

27. Vukovic R, Mitrovic K, Milenkovic T, Todorovic S, Soldatovic I, Sipetic-Grujicic S, Zdravkovic D. Insulin-sensitive obese children display a favorable metabolic profile. Eur J Pediatr. 2013; 172:201–206.

28. Weigensberg MJ, Ball GD, Shaibi GQ, Cruz ML, Gower BA, Goran MI. Dietary fat intake and insulin resistance in black and white children. Obes Res. 2005; 13:1630–1637.

29. Ministry of Health and Welfare (KR). The Korean Nutrition Society. Dietary Reference Intakes for Koreans 2015. Sejong: Ministry of Health and Welfare;2016.

30. National Institutes of Health (US). Nutrient recommendations: dietary reference intakes (DRI) [Internet]. accessed on 1 June 2017. Available at https://ods.od.nih.gov/Health_Information/Dietary_Reference_Intakes.aspx.

31. Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004; 79:379–384.

32. Zamrazilova H, Weiss R, Hainer V, Aldhoon-Hainerová I. Cardiometabolic health in obese adolescents is related to length of obesity exposure: a pilot study. J Clin Endocrinol Metab. 2016; 101:3088–3095.

33. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med. 2013; 159:758–769.